Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Embattled hedge fund SAC Capital continues to outperform with 13% gains YTD

Thursday, September 26, 2013

Komfie Manalo, Opalesque Asia:

Embattled hedge fund manager Steven Cohen continues to defy the odds as SAC Capital Advisors’s main hedge fund outperforms its rivals and registered 13% gains as of last Friday, various media reported. Meanwhile, the $14bn firm is facing criminal charges for alleged insider trading.

SAC Capital’s good fortune outweighs its counterparts as Reuters reported that the average hedge fund earned about 4% YTD as at end August.

Even at the height of the emerging markets selloff in June, when most hedge funds registered negative returns, his fund posted a 1.5% gain during the month (+8.25% YTD). In June, the average hedge fund lost about 2.1%, according to Bank of America Merrill Lynch

Last July, U.S. Federal prosecutors indicted SAC Capital and accused the firm of promoting a culture that allows its portfolio managers and analyst to gather or trade using inside information on various stocks while employed at the firm. U.S. attorney Preet Bharara described SAC as a "magnet for market cheaters".

As some investors have been pulling out, SAC has had to let go of some sales and marketing staff. Reuters also reports that to avoid an exodus from the traders, SAC committed to paying them a 3.5% bonus next year if the......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its